Skip to main content

BFSG, LLC

SEC CIK
0001706836
Latest filing
Jul 20, 2026

JANX holding history

Janux Therapeutics, Inc. in every 13F filed by BFSG, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

JANX overviewAll 13F holders of JANXFull Q2 2026 holdings

Shares (Q2 2026)
100
Value
$1.54K
% of portfolio
<0.1%
Quarters held
9
Since Q2 2024
Holdings of JANX by BFSG, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026100$1.54K<0.1%00.0%UnchangedHolders
Q1 2026100$1.39K<0.1%00.0%UnchangedHolders
Q4 2025100$1.38K<0.1%00.0%UnchangedHolders
Q3 2025100$2.44K<0.1%00.0%UnchangedHolders
Q2 2025100$2.31K<0.1%00.0%UnchangedHolders
Q1 2025100$2.70K<0.1%00.0%UnchangedHolders
Q4 2024100$5.35K<0.1%−200−66.7%ReducedHolders
Q3 2024300$13.6K<0.1%−100−25.0%ReducedHolders
Q2 2024400$16.8K<0.1%+400NewHolders